Houlihan Lokey Advises BioMatrix Specialty Infusion Pharmacy
Houlihan Lokey is pleased to announce that BioMatrix Specialty Infusion Pharmacy, a portfolio company of ACON Investments and Triton Pacific Healthcare Partners, has been acquired by Frazier Healthcare Partners. Click here to learn more: https://cdn.hl.com/email/da-2024-cf-hc-biomatrix.html
Principal RTW Specialty Management Group
8 个月Congratulations ??
Chief Executive Officer at AOM Infusion
8 个月Congratulations!
Congrats guys!